Trexquant Investment LP Revolution Medicines, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $1.06 Million - $1.41 Million	52,181 New	52,181 $1.4 Million
Q2 2022 Aug 11, 2022	BUY	$14.54 - $27.17 $230,967 - $431,595	15,885 Added 170.31%	25,212 $491,000
Q1 2022 May 13, 2022	SELL	$17.31 - $26.4 $174,363 - $265,927	-10,073 Reduced 51.92%	9,327 $238,000
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $472,390 - $653,780	19,400 New	19,400 $488,000
Q3 2021 Nov 12, 2021	SELL	$23.95 - $33.41 $241,631 - $337,073	-10,089 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$29.0 - $47.44 $47,850 - $78,276	1,650 Added 19.55%	10,089 $320,000
Q1 2021 May 13, 2021	BUY	$37.21 - $54.43 $314,015 - $459,334	8,439 New	8,439 $387,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.